Panangala V S, Haynes T B, Schultz R D, Mitra A
Vet Immunol Immunopathol. 1986 Sep;13(1-2):71-84. doi: 10.1016/0165-2427(86)90050-4.
Immunomodulation with killed Propionibacterium acnes was attempted in guinea pigs simultaneously vaccinated with Brucella abortus strain 19. Two groups, each comprised of 9 guinea pigs, were injected by different routes (s.c. and or i.v.) with 1.4 mg of P. acnes and 5 X 10(8) CFU of B. abortus, S-19, while 3 other groups each received either P. acnes, B. abortus S-19, or saline (s.c.). The antibody titers to B. abortus measured at 6, 10 and 14 weeks after vaccination indicated no significant (P less than 0.01) response in the 2 groups immunopotentiated with P. acnes concurrent with B. abortus S-19 vaccination. The delayed hypersensitivity response to 3 Brucella antigens conducted 8 weeks after immunization did not show a significant difference between the B. abortus S-19 vaccinated group compared with the 2 groups immunopotentiated and vaccinated. However, the proliferative response of lymphocytes to the B. abortus soluble antigen diluted 1:100 indicated significantly enhanced blastogenesis in the (s.c.) immunopotentiated and immunized guinea pigs compared with the B. abortus S-19 vaccinated group. A slightly enhanced response was also observed in the group immunopotentiated (i.v.) and vaccinated (s.c.). The guinea pigs were challenged with B. abortus strain 2308 and necropsied 4 weeks later. The mean splenic CFU of the Brucella in the group immunopotentiated (i.v.) and vaccinated (s.c.) was significantly decreased when compared with the guinea pigs vaccinated with B. abortus S-19 alone. These findings indicated that P. acnes administered simultaneously with B. abortus S-19 vaccine was able to augment the immune response in guinea pigs. Immunomodulation as evidenced by enhanced clearance of B. abortus from the spleens of immunopotentiated animals was presumably brought about by activated macrophages or a T-cell mediated cytolytic mechanism or both.
在用布鲁氏菌19株同时对豚鼠进行疫苗接种的情况下,尝试用灭活的痤疮丙酸杆菌进行免疫调节。两组豚鼠,每组9只,通过不同途径(皮下和静脉内)注射1.4毫克痤疮丙酸杆菌和5×10⁸CFU的流产布鲁氏菌S-19,而其他三组分别接受痤疮丙酸杆菌、流产布鲁氏菌S-19或生理盐水(皮下注射)。在接种疫苗后6周、10周和14周测量的针对流产布鲁氏菌的抗体滴度表明,在用痤疮丙酸杆菌与流产布鲁氏菌S-19同时接种进行免疫增强的两组中,没有显著(P<0.01)反应。在免疫8周后对三种布鲁氏菌抗原进行的迟发型超敏反应在接种流产布鲁氏菌S-19的组与两组免疫增强并接种疫苗的组之间没有显示出显著差异。然而,淋巴细胞对稀释1:100的流产布鲁氏菌可溶性抗原的增殖反应表明,与接种流产布鲁氏菌S-19的组相比,皮下免疫增强并接种疫苗的豚鼠的母细胞生成显著增强。在静脉内免疫增强并皮下接种疫苗的组中也观察到了略有增强的反应。用流产布鲁氏菌2308株对豚鼠进行攻毒,并在4周后进行剖检。与单独接种流产布鲁氏菌S-19的豚鼠相比,静脉内免疫增强并皮下接种疫苗的组中布鲁氏菌的平均脾脏CFU显著降低。这些发现表明,与流产布鲁氏菌S-19疫苗同时给予痤疮丙酸杆菌能够增强豚鼠的免疫反应。免疫增强动物脾脏中流产布鲁氏菌清除率提高所证明的免疫调节作用,可能是由活化的巨噬细胞或T细胞介导的细胞溶解机制或两者共同引起的。